Ultragenyx Pharmaceutical, Inc. (RARE)
16.64
+0.34
(+2.12%)
USD |
NASDAQ |
Nov 03, 16:00
15.60
-1.04
(-6.28%)
After-Hours: 17:43
Ultragenyx Pharmaceutical Cash and Short Term Investments (Quarterly) : 301.00M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 301.00M |
| March 31, 2026 | 421.00M |
| December 31, 2025 | 693.00M |
| September 30, 2025 | 435.07M |
| June 30, 2025 | 496.62M |
| March 31, 2025 | 502.92M |
| December 31, 2024 | 616.83M |
| September 30, 2024 | 627.78M |
| June 30, 2024 | 769.99M |
| March 31, 2024 | 418.38M |
| December 31, 2023 | 579.22M |
| September 30, 2023 | 444.07M |
| June 30, 2023 | 553.68M |
| March 31, 2023 | 631.32M |
| December 31, 2022 | 748.62M |
| September 30, 2022 | 889.19M |
| June 30, 2022 | 543.31M |
| March 31, 2022 | 598.54M |
| December 31, 2021 | 740.20M |
| September 30, 2021 | 747.12M |
| June 30, 2021 | 855.76M |
| March 31, 2021 | 976.10M |
| December 31, 2020 | 1.212B |
| September 30, 2020 | 766.37M |
| June 30, 2020 | 814.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 663.44M |
| December 31, 2019 | 755.39M |
| September 30, 2019 | 527.22M |
| June 30, 2019 | 618.45M |
| March 31, 2019 | 715.67M |
| December 31, 2018 | 459.98M |
| September 30, 2018 | 503.75M |
| June 30, 2018 | 547.78M |
| March 31, 2018 | 541.89M |
| December 31, 2017 | 234.95M |
| September 30, 2017 | 371.53M |
| June 30, 2017 | 400.11M |
| March 31, 2017 | 425.46M |
| December 31, 2016 | 381.56M |
| September 30, 2016 | 397.84M |
| June 30, 2016 | 393.28M |
| March 31, 2016 | 413.15M |
| December 31, 2015 | 437.15M |
| September 30, 2015 | 448.38M |
| June 30, 2015 | 327.10M |
| March 31, 2015 | 343.64M |
| December 31, 2014 | 187.49M |
| September 30, 2014 | 201.19M |
| June 30, 2014 | 153.27M |
| March 31, 2014 | 165.40M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.055B |
| AbbVie, Inc. | -- |
| Krystal Biotech, Inc. | -- |
| BridgeBio Pharma, Inc. | 1.539B |
| Alnylam Pharmaceuticals, Inc. | 3.587B |